Podophyllotoxin

Source: Wikipedia, the free encyclopedia.
Podophyllotoxin
Clinical data
Trade namesCondylox,[1] Wartec, others
Other names(5R,5aR,8aR,9R)-9-hydroxy-5-(3,4,5-trimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d] [1,3]dioxol-6(5aH)-one
AHFS/Drugs.comMonograph
MedlinePlusa684055
Pregnancy
category
  • C
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Elimination half-life1.0 to 4.5 hours.
Identifiers
  • (10R,11R,15R,16R)-16-hydroxy-10-(3,4,5-trimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.03,7.011,15]hexadeca-1,3(7),8-trien-12-one
JSmol)
Melting point183.3 to 184 °C (361.9 to 363.2 °F)
  • COc1cc(cc(c1OC)OC)[C@@H]2c3cc4c(cc3[C@@H]([C@@H]5[C@@H]2C(=O)OC5)O)OCO4
  • InChI=1S/C22H22O8/c1-25-16-4-10(5-17(26-2)21(16)27-3)18-11-6-14-15(30-9-29-14)7-12(11)20(23)13-8-28-22(24)19(13)18/h4-7,13,18-20,23H,8-9H2,1-3H3/t13-,18+,19-,20-/m0/s1 checkY
  • Key:YJGVMLPVUAXIQN-XVVDYKMHSA-N checkY
 ☒NcheckY (what is this?)  (verify)

Podophyllotoxin (PPT) is the active ingredient in Podofilox, which is a medical cream that is used to treat

HPV infections without external warts.[2] It can be applied either by a healthcare provider or the person themselves.[2]

It is a non-alkaloid toxin lignin extracted from the roots and rhizomes of Podophyllum species.[3] A less refined form known as podophyllum resin is also available, but has greater side effects.[4][5]

Podophyllotoxin was first isolated in pure form in 1880 by Valerian Podwyssotzki (1818 – 28 January 1892), a Polish-Russian privatdozent at the University of Dorpat (now: Tartu, Estonia) and assistant at the Pharmacological Institute there.[6][7][8]

It is on the World Health Organization's List of Essential Medicines.[9]

Medical uses

Podophyllotoxin possesses a large number of medical applications, as it is able to stop replication of both cellular and viral DNA by binding necessary enzymes. It can additionally destabilize microtubules and prevent cell division. Because of these interactions it is considered an antimitotic drug, although modern medicine instead use less orally toxic derivatives when such effect is wanted.[10]

Podophyllotoxin cream is commonly prescribed as a potent topical antiviral.[11] It is used for the treatment of HPV infections with external warts as well as molluscum contagisum infections.[11] 0.5% PPT cream is prescribed for twice daily applications for 3 days followed by 4 days with no application, this weekly cycle is repeated for 4 weeks.[12] It can also be prescribed as a gel, as opposed to cream. PPT is also sold under the names condyline and warticon.[13]

Adverse effects

The most common side effects of podophyllotoxin cream are typically limited to irritation of tissue surrounding the application site, including burning, redness, pain, itching, swelling.[14] Application can be immediately followed by burning or itching. Small sores, itching and peeling skin can also follow, for these reasons it is recommended that application be done in a way that limits contact with surrounding, uninfected tissue[15]

Neither podophyllin resin nor podophyllotoxin lotions or gels are used during pregnancy because these medications have been shown to be embryotoxic in both mice and rats. Additionally, antimitotic agents are not typically recommended during pregnancy.[16] Additionally, it has not been determined if podophyllotoxin can pass into breast milk from topical applications and therefore it is not recommended for breastfeeding women.[17]

Podophyllotoxin cream is safe for topical use; however, it can cause CNS depression as well as enteritis if ingested. The podophyllum resin from which podophyllotoxin is derived has the same effect.[18]

Mechanism of action

Podophyllotoxin destabilizes microtubules by binding tubulin and thus preventing cell division.

HSP60 or chaperonin protein.[25][26][27]

Furthermore, podophyllotoxin is classified as an arytetralin lignan for[dubious ] its ability to bind and deactivate DNA.[28] It and its derivates bind Topo II and prevent its ability to catalyze rejoining of DNA that has been broken for replication. Lastly, experimental evidence has shown that these arytetralin lignans can interact with cellular factors to create chemical DNA adducts, thus further deactivating DNA.[28]

Chemistry

Structural characteristic

The structure of podophyllotoxin was first elucidated in the 1930s.

methoxy groups, and an acetal.[30]

Ring assignment and numbering of podophyllotoxin

Derivatives of podophyllotoxin are synthesized as properties of the rings and carbon 1 through 4 are diversified. For example, ring A is not essential to antimitotic activity. Aromatization of ring C leads to loss of activity, possibly from ring E no longer being placed on the axial position. In addition, the stereochemistry at C-2 and C-3 configures a trans-lactone, which has more activity than the cis counterpart. Chirality at C-1 is also important as it implies an axial position for ring E.[30]

Biosynthesis

The biosynthetic route of podophyllotoxin was not completely eludicidated for many years; however, in September 2015, the identity of the six missing enzymes in podophyllotoxin biosynthesis were reported for the first time.

NADPH to first lariciresinol, and ultimately secoisolariciresinol. Lactonization on secoisolariciresinol gives rise to matairesinol. Secoisolariciresinol is assumed to be converted to yatein through appropriate quinomethane intermediates,[10]
leading to podophyllotoxin.

Proposed biosynthetic pathway leading to podophyllotoxin

A sequence of enzymes involved has been reported to be

mayapple enabled production of the etoposide aglycone in tobacco plants.[31]

Chemical synthesis

Podophyllotoxin has been successfully synthesized in a laboratory; however, synthesis mechanisms require many steps, resulting in a low overall yield. It therefore remains more efficient to obtain podophyllotoxin from natural sources.[32]

Four routes have been used to synthesize podophyllotoxin with varying success: an oxo ester route,[33] lactonization of a dihydroxy acid,[34] cyclization of a conjugate addition product,[35] and a Diels-Alder reaction.[36]

Derivatives

Podophyllotoxin and its derivatives are used as

antitumor agents. Podophyllotoxin derived antitumor agents include etoposide and teniposide.[10][37] These drugs have been successfully used in therapy against numerous cancers including testicular, breast, pancreatic, lung, stomach, and ovarian cancers.[32]

Derivatives of podophyllotoxin that have been engineered for their ability to fight tumors.[38]

Natural abundance

Podophyllotoxin is present at concentrations of 0.3% to 1.0% by mass in the

American mayapple (Podophyllum peltatum).[21][39] Another common source is the rhizome of Sinopodophyllum hexandrum Royle (Berberidaceae
).

It is

References

  1. ^ "What is Condylox?" (in German). Retrieved 2018-08-15.
  2. ^ a b c "Podofilox". The American Society of Health-System Pharmacists. Retrieved 8 December 2016.
  3. PMID 19149581
    .
  4. ^ "Podophyllum Resin". The American Society of Health-System Pharmacists. Retrieved 8 December 2016.
  5. .
  6. ^ See:
  7. .
  8. .
  9. . WHO/MHP/HPS/EML/2021.02.
  10. ^ .
  11. ^ .
  12. ^ "Podofilox Monograph for Professionals - Drugs.com". Drugs.com. Retrieved 2018-05-06.
  13. ^ "Podophyllotoxin for anogenital warts; Podophyllotoxin info". patient.info. Retrieved 2018-05-06.
  14. PMID 11350195
    .
  15. ^ "PRODUCT INFORMATION WARTEC® SOLUTION" (PDF). GlaxoSmithKline Australia Pty Ltd. Retrieved 6 January 2013.
  16. PMID 2742385
    .
  17. ^ "Podophyllotoxin | DermNet New Zealand". www.dermnetnz.org. Retrieved 2018-05-06.
  18. PMID 458391
    .
  19. .
  20. .
  21. ^ .
  22. .
  23. ^ .
  24. .
  25. .
  26. .
  27. .
  28. ^ .
  29. .
  30. ^ .
  31. ^ .
  32. ^ .
  33. .
  34. .
  35. .
  36. .
  37. .
  38. .
  39. .

Further reading